Zacks.com Announces That Dr. Melvin Pasternak Highlights the Following Stocks: Atwood Oceanics, Biosite, and F5 Networks.

CHICAGO -- Dr. Melvin Pasternak expects a mild pullback. Read this experts' recap of the S&P 500 and learn about Atwood Oceanics (NYSE:ATW), Biosite (NASDAQ:BSTE), and F5 Networks (NASDAQ:FFIV). Dr. Melvin Pasternak is the editor of the StreetAuthority Swing Trader newsletter. Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84

Highlights from the May 25th Featured Expert column by Dr. Melvin Pasternak include:

Stock Updates

With the price of crude oil having held well above major trendline support, oil service stocks are rebounding from deeply depressed levels. Atwood Oceanics (NYSE:ATW) has found support near $50 and had a nice rally Wednesday (5/25), gaining more than $2.50.

Medical diagnostics company Biosite (NASDAQ:BSTE) broke out to a new high on Wednesday (5/25). The stock should now find support near $62.50 -- a level of former resistance.

Computer network maker F5 Networks (NASDAQ:FFIV) is riding its upper Bollinger band higher. FFIV broke through $50 convincingly on Wednesday (5/25), managing to gain more than $1 in a down market.

Read Dr. Melvin Pasternak's commentary on the S&P 500 and receive more information on the stocks above as well as additional stocks by clicking: http://at.zacks.com/?id=85

About Zacks Featured Experts

Successful investing requires professional advice from knowledgeable experts who can help investors achieve their financial goals in good markets and improve their portfolios, especially in bad ones. That is why Zacks Investment Research has assembled the best investment experts in the business to offer their powerful advisory newsletters on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc.

Additional recommendations from Zacks.com Featured Experts are highlighted in the free investment newsletter, Profit from the Pros. Each issue highlights several Featured Experts in this free e-mail newsletter. Register for a free subscription to "Profit from the Pros" at: http://at.zacks.com/?id=86

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind Zacks work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. The goal is to unlock these pros' profitable insights for individual investors hard-pressed to find this valuable information in one source. A free subscription to "Profit from the Pros" weekly e-mail newsletter provides the best way to use these experts' insights for more profitable investing. Register now for a free subscription to the Profit from the Pros newsletter at http://at.zacks.com/?id=87

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.